Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Anal Carcinoma”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Early research (Phase 1)Not Yet RecruitingNCT06358053
What this trial is testing

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers+1 more
Corregene Biotechnology Co., Ltd 24
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)UnknownNCT03944252
What this trial is testing

Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS)

Who this might be right for
Squamous Cell Anal Carcinoma
Gruppo Oncologico del Nord-Ovest 54
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Who this might be right for
Advanced CancerAnal CarcinomaAnal Cancer+22 more
Merck Sharp & Dohme LLC 1,609
Early research (Phase 1)Looking for participantsNCT07217171
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the LungEsophageal Squamous Cell Carcinoma+8 more
EvolveImmune United, Inc 160
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Large-scale testing (Phase 3)Study completedNCT04472429
What this trial is testing

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation 308
Early research (Phase 1)Study completedNCT04328740
What this trial is testing

Phase 1 Study of Oral TP-1454

Who this might be right for
Advanced Solid TumorAnal Cancer
Sumitomo Pharma America, Inc. 31
Testing effectiveness (Phase 2)WithdrawnNCT04499352
What this trial is testing

Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Who this might be right for
Anal Canal Squamous Cell Carcinoma
Boehringer Ingelheim
Not applicableEnded earlyNCT02900248
What this trial is testing

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Who this might be right for
NeoplasmsLung NeoplasmsColon Neoplasms+22 more
CureOne 23
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Testing effectiveness (Phase 2)Ended earlyNCT00955240
What this trial is testing

Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer

Who this might be right for
Anal Cancer
UNICANCER 16
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Load More Results